Survey highlights widespread opposition to Alabama's law restricting in vitro fertilization (IVF) access; investigation focuses on potential anticompetitive practices; Medicare weighs options for implementing a new program to deliver healthy meals to seniors with chronic conditions.
Majority Disagrees With Alabama IVF Ruling
A recent survey revealed that most Americans oppose the Alabama Supreme Court's controversial in vitro fertilization (IVF) ruling, holding people legally responsible for destroying genetic material, according to The Hill. The findings underscore widespread disagreement with the law's implications for reproductive rights and access to assisted reproductive technologies. Critics argue that such restrictions undermine individual autonomy and perpetuate inequality in accessing reproductive health care.
DOJ Launches Antitrust Probe into UnitedHealth's Dominance
The Department of Justice (DOJ) has initiated an antitrust investigation into UnitedHealth, probing its extensive presence in health care, including insurance, drug benefits, and physician groups, according to The Wall Street Journal. Investigators are scrutinizing relationships between UnitedHealthcare and Optum, questioning potential anticompetitive effects on rivals and consumers. The inquiry reflects a broader effort by the Biden administration to curb monopolistic practices in the health care industry and ensure fair competition for consumers and providers alike.
Medicare Explores Food as Medicine Initiative to Enhance Health Care
With around 12% of traditional Medicare beneficiaries suffering from heart failure and a quarter grappling with diabetes, the prospect of delivering premade healthy meals to sick senior citizens has gained attention, according to Stat. Although some urge immediate action, others advocate for a congressional directive, highlighting the complexities and challenges of integrating such a program into traditional health care. Medicare officials are currently weighing various options, considering potential benefits and constraints of the program.
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More